
The study aim is to assess the effectiveness and safety of the application of a topical treatment combining two commonly used medicines for painful intercourse with penetration.
Participants need to be:
If you are interested in participating FIND OUT MORE HERE.
Dr Karen Chan Principal Investigator
For more information please contact us today.
If you have a specific enquiry for our WHRIA specialists
Click HereAny information about you that is obtained in connection with a research study will remain confidential and will be disclosed only with your permission. To ensure confidentiality, your information will be identified only by initials, date of birth and a study allocated number. The results of the study may be published or disclosed to other people in a way that will not identify you. The study will be conducted in accordance all relevant national and international regulatory guidelines to minimise negative impact on participants. Your medical records insofar as they relate to this study may be reviewed by officials of government related bodies or of any commercial company involved in this study. However, no personal details will be released. All data will be stored by the Women’s Health & Research Institute of Australia, under controlled (locked) access. Data will be retained for a minimum of ten years. Materials (including paper documents and computer discs) will be destroyed using an industrial shredding process.
If you have a specific enquiry for our WHRIA specialists
Click Here© 2025 Women's Health & Research Institute of Australia. Privacy Policy | Terms of Use | Website by Phil Kurth